8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)
Published . Updated .
Filed: 2026-10-14 AccNo: 0001689375-26-000057 Size: 501 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- TRDA Entrada Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-14 AccNo: 0001689375-26-000057 Size: 501 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Entrada Therapeutics (TRDA) has moved since 14 Oct 2026
Since the first closing price after “8-K - Entrada Therapeutics, Inc. (0001689375) (Filer),” Entrada Therapeutics (TRDA) is +1.47%. The S&P 500 fund (SPY) is -0.67% over the same days, a +2.14% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -1.49% | final price |
| GLD | the next day | +0.27% | final price |
| GLD | two days later | +0.10% | final price |
| GLD | three days later | -0.52% | final price |
| GLD | three days earlier | +0.77% | final price |
| GLD | five days earlier | -1.52% | final price |
| QQQ | that day | -1.97% | final price |
| QQQ | the next day | -2.08% | final price |
| QQQ | two days later | -4.55% | final price |
| QQQ | three days later | -3.41% | final price |
| QQQ | three days earlier | +1.02% | final price |
| QQQ | five days earlier | +1.90% | final price |
| SPY | that day | -1.08% | final price |
| SPY | the next day | -0.80% | final price |
| SPY | two days later | -1.89% | final price |
| SPY | three days later | -1.47% | final price |
| SPY | three days earlier | +0.06% | final price |
| SPY | five days earlier | -0.11% | final price |
| TLT | that day | +0.68% | final price |
| TLT | the next day | +2.09% | final price |
| TLT | two days later | +2.15% | final price |
| TLT | three days later | +1.42% | final price |
| TLT | three days earlier | -0.50% | final price |
| TLT | five days earlier | -1.52% | final price |
| Entrada Therapeutics (TRDA) | that day | -6.38% | final price |
| Entrada Therapeutics (TRDA) | the next day | -1.65% | final price |
| Entrada Therapeutics (TRDA) | two days later | -10.08% | final price |
| Entrada Therapeutics (TRDA) | three days later | -0.82% | final price |
| Entrada Therapeutics (TRDA) | three days earlier | +16.67% | final price |
| Entrada Therapeutics (TRDA) | five days earlier | +15.43% | final price |
Who is named in “8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)”
Companies tied to this story
- TRDA Entrada Therapeutics
For “8-K - Entrada Therapeutics, Inc. (0001689375) (Filer),” Entrada Therapeutics (TRDA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> TRDA
How “8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)” reaches Entrada Therapeutics (TRDA)
On 14 Oct 2026, “8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)” is the story that connects Entrada Therapeutics (TRDA) to this story.
For Entrada Therapeutics (TRDA), the reason on file says SEC 8-K filing -> direct issuer disclosure -> TRDA
Price levels for Entrada Therapeutics (TRDA)
TRDA traded between 4.11 and 4.96 across 4 sessions. The latest close on file is 4.84.
What the saved facts support for Entrada Therapeutics (TRDA)
17 out of 100
“8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)” scores 17 out of 100. The score uses 1 sources, a -0.85% difference versus the S&P 500 (SPY), and 1 linked companies.